RECURSION PHARMACEUTICALS-A · CUSIP 75629V104 · CIK 1668343
As of 2026-06-30, DCVC Opportunity Fund II GP, LLC reported 3.95M RXRX (shares), valued at $14.50M, or 84.30% of its reported non-derivative portfolio. Filed 2026-08-14.
Verify history & sources →Shares unchanged; reported value increased 19.54%, and weight changed -3.18 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.
Left: % · Right: Shares · Independently scaled axes
Exact data and methodology
Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.
| Quarter | Weight | Quantity | Source |
|---|---|---|---|
| Q2 2026 | 84.30% | 3,951,141 | SEC filing ↗Filed Aug 14, 2026 |
| Q1 2026 | 87.48% | 3,951,141 | SEC filing ↗Filed May 15, 2026 |
| Q4 2025 | 97.42% | 3,951,141 | SEC filing ↗Filed Feb 17, 2026 |
| Q3 2025 | 100.00% | 3,951,141 | SEC filing ↗Filed Nov 14, 2025 |
| Q2 2025 | 17.35% | 3,951,141 | SEC filing ↗Filed Aug 14, 2025 |
| Q1 2025 | 25.65% | 3,951,141 | SEC filing ↗Filed May 15, 2025 |
| Q4 2024 | 23.64% | 3,951,141 | SEC filing ↗Filed Feb 14, 2025 |
| Q3 2024 | 26.74% | 3,951,141 | SEC filing ↗Filed Nov 14, 2024 |
| Q2 2024 | 44.95% | 3,951,141 | SEC filing ↗Filed Aug 14, 2024 |
| Q1 2024 | 55.14% | 3,951,141 | SEC filing ↗Filed May 15, 2024 |
| Q4 2023 | 48.18% | 3,951,141 | SEC filing ↗Filed Feb 14, 2024 |
| Q3 2023 | Not reported | Not reported | No filing this quarter |
History & evidence by quarter
| Quarter | Weight | Quantity | Value | Change explained | Source |
|---|---|---|---|---|---|
| Q3 2023 | Not reported | — | — | The manager filed nothing for this quarter; a missing quarter is not treated as zero holdings. | — |
| Q4 2023 | 48.18% | 3,951,141 | $38.96M | The prior quarter is outside the free window. Sign in for the comparison. | SEC filing ↗ Filed Feb 14, 2024 |
| Q1 2024 | 55.14% | 3,951,141 | $39.39M | Shares unchanged; reported value increased 1.12%, and weight changed +6.96 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed May 15, 2024 |
| Q2 2024 | 44.95% | 3,951,141 | $29.63M | Shares unchanged; reported value decreased 24.77%, and weight changed -10.19 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Aug 14, 2024 |
| Q3 2024 | 26.74% | 3,951,141 | $26.04M | Shares unchanged; reported value decreased 12.13%, and weight changed -18.21 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Nov 14, 2024 |
| Q4 2024 | 23.64% | 3,951,141 | $26.71M | Shares unchanged; reported value increased 2.58%, and weight changed -3.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Feb 14, 2025 |
| Q1 2025 | 25.65% | 3,951,141 | $20.90M | Shares unchanged; reported value decreased 21.75%, and weight changed +2.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed May 15, 2025 |
| Q2 2025 | 17.35% | 3,951,141 | $19.99M | Shares unchanged; reported value decreased 4.35%, and weight changed -8.30 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Aug 14, 2025 |
| Q3 2025 | 100.00% | 3,951,141 | $19.28M | Shares unchanged; reported value decreased 3.56%, and weight changed +82.65 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Nov 14, 2025 |
| Q4 2025 | 97.42% | 3,951,141 | $16.16M | Shares unchanged; reported value decreased 16.19%, and weight changed -2.58 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Feb 17, 2026 |
| Q1 2026 | 87.48% | 3,951,141 | $12.13M | Shares unchanged; reported value decreased 24.94%, and weight changed -9.94 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed May 15, 2026 |
| Q2 2026 | 84.30% | 3,951,141 | $14.50M | Shares unchanged; reported value increased 19.54%, and weight changed -3.18 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Aug 14, 2026 |
Take these holdings further.
This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1668343","quarter":"2026Q2","cusip":"75629V104"}
get_institutional_manager_history
{"cik":"1668343","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.